Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas

MLA

Catherine Burkhart, et al. “Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.” Cancer Research, vol. 76, no. 22, Oct. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72838778b44f256037445e4cbcc3eef6&authtype=sso&custid=ns315887.

APA

Catherine Burkhart, Joseph J. Skitzki, Daria Fleyshman, Gary Haderski, Nickolay Neznanov, Katerina Gurova, Minhyung Kim, Chandler Wilfong, Patricia Stanhope-Baker, Andrei Purmal, & Andrei V. Gudkov. (2015). Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas. Cancer Research, 76(22).

Chicago

Catherine Burkhart, Joseph J. Skitzki, Daria Fleyshman, Gary Haderski, Nickolay Neznanov, Katerina Gurova, Minhyung Kim, et al. 2015. “Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas.” Cancer Research 76 (22). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....72838778b44f256037445e4cbcc3eef6&authtype=sso&custid=ns315887.